» Articles » PMID: 33049983

Pericyte-Endothelial Interactions in the Retinal Microvasculature

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2020 Oct 14
PMID 33049983
Citations 74
Authors
Affiliations
Soon will be listed here.
Abstract

Retinal microvasculature is crucial for the visual function of the neural retina. Pericytes and endothelial cells (ECs) are the two main cellular constituents in the retinal microvessels. Formation, maturation, and stabilization of the micro-vasculatures require pericyte-endothelial interactions, which are perturbed in many retinal vascular disorders, such as retinopathy of prematurity, retinal vein occlusion, and diabetic retinopathy. Understanding the cellular and molecular mechanisms of pericyte-endothelial interaction and perturbation can facilitate the design of therapeutic intervention for the prevention and treatment of retinal vascular disorders. Pericyte-endothelial interactions are indispensable for the integrity and functionality of retinal neurovascular unit (NVU), including vascular cells, retinal neurons, and glial cells. The essential autocrine and paracrine signaling pathways, such as Vascular endothelial growth factor (VEGF), Platelet-derived growth factor subunit B (PDGFB), Notch, Angipointein, Norrin, and Transforming growth factor-beta (TGF-β), have been well characterized for the regulation of pericyte-endothelial interactions in the neo-vessel formation processes (vasculogenesis and angiogenesis) during embryonic development. They also play a vital role in stabilizing and remodeling mature vasculature under pathological conditions. Awry signals, aberrant metabolisms, and pathological conditions, such as oxidative stress and inflammation, can disrupt the communication between pericytes and endothelial cells, thereby resulting in the breakdown of the blood-retinal barrier (BRB) and other microangiopathies. The emerging evidence supports extracellular exosomes' roles in the (mis)communications between the two cell types. This review summarizes the essential knowledge and updates about new advancements in pericyte-EC interaction and communication, emphasizing the retinal microvasculature.

Citing Articles

Comparative analysis of retinal vascular structural parameters in populations with different glucose metabolism status based on color fundus photography and artificial intelligence.

Chen N, Zhu Z, Gong D, Xu X, Hu X, Yang W Front Cell Dev Biol. 2025; 13:1550176.

PMID: 39963156 PMC: 11830720. DOI: 10.3389/fcell.2025.1550176.


USP39 promotes retinal pathological angiogenesis in retinopathy of prematurity by stabilizing SIRT2 expression through deubiquitination.

Wang X, Zhang P, Xie J, Zuo X Int Ophthalmol. 2025; 45(1):39.

PMID: 39853525 DOI: 10.1007/s10792-025-03410-y.


Innate immune cells in vascular lesions: mechanism and significance of diversified immune regulation.

Wu J, Qian Y, Yang K, Zhang S, Zeng E, Luo D Ann Med. 2025; 57(1):2453826.

PMID: 39847394 PMC: 11758805. DOI: 10.1080/07853890.2025.2453826.


Biglycan stimulates retinal pathological angiogenesis via up-regulation of CXCL12 expression in pericytes.

Liu M, Zhao P, Feng H, Yang Y, Zhang X, Chen E FASEB J. 2025; 39(1):e70262.

PMID: 39760177 PMC: 11701870. DOI: 10.1096/fj.202401903R.


Leveraging the synergy between anti-angiogenic therapy and immune checkpoint inhibitors to treat digestive system cancers.

Xu Q, Shao D Front Immunol. 2024; 15:1487610.

PMID: 39691707 PMC: 11649667. DOI: 10.3389/fimmu.2024.1487610.


References
1.
Dagher Z, Gerhardinger C, Vaz J, Goodridge M, Tecilazich F, Lorenzi M . The Increased Transforming Growth Factor-β Signaling Induced by Diabetes Protects Retinal Vessels. Am J Pathol. 2017; 187(3):627-638. PMC: 5397667. DOI: 10.1016/j.ajpath.2016.11.007. View

2.
Saunders K, Smith S, DAmore P . An activated form of transforming growth factor beta is produced by cocultures of endothelial cells and pericytes. Proc Natl Acad Sci U S A. 1989; 86(12):4544-8. PMC: 287307. DOI: 10.1073/pnas.86.12.4544. View

3.
Wang J, Huang T, Su P, Chang P . An updated review of long-term outcomes from randomized controlled trials in approved pharmaceuticals for diabetic macular edema. Eye Sci. 2016; 30(4):176-83. View

4.
Armulik A, Abramsson A, Betsholtz C . Endothelial/pericyte interactions. Circ Res. 2005; 97(6):512-23. DOI: 10.1161/01.RES.0000182903.16652.d7. View

5.
Nguyen Q, De Falco S, Behar-Cohen F, Lam W, Li X, Reichhart N . Placental growth factor and its potential role in diabetic retinopathy and other ocular neovascular diseases. Acta Ophthalmol. 2016; 96(1):e1-e9. PMC: 5811779. DOI: 10.1111/aos.13325. View